The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk-adapted local therapy and intensive chemotherapy in patients with high-risk rhabdomyosarcoma.
 
Michael W. Bishop
Consulting or Advisory Role - Fennec Pharma; Pfizer
 
Yimei Li
No Relationships to Disclose
 
Rachel Christine Brennan
No Relationships to Disclose
 
Sara Michele Federico
No Relationships to Disclose
 
Elizabeth Stewart
No Relationships to Disclose
 
Mark Edward Hatley
Consulting or Advisory Role - Servier
 
Sara Helmig
No Relationships to Disclose
 
John Thomas Lucas
No Relationships to Disclose
 
Christopher L Tinkle
Research Funding - Kazia Therapeutics
 
Andrew M. Davidoff
No Relationships to Disclose
 
Mary B McCarville
No Relationships to Disclose
 
Karen H. Albritton
No Relationships to Disclose
 
Daniel J. Indelicato
No Relationships to Disclose
 
Alberto S. Pappo
Honoraria - Bayer; Lilly; Roche
Consulting or Advisory Role - Debbio; EUSA Pharma; Loxo/Bayer; Merck
 
Matthew J. Krasin
Consulting or Advisory Role - Debiopharm Group